{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:06:30Z","timestamp":1763003190483,"version":"3.45.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":417,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007249","name":"University of Minnesota","doi-asserted-by":"publisher","award":["P30 CA77598"],"award-info":[{"award-number":["P30 CA77598"]}],"id":[{"id":"10.13039\/100007249","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jtct.2022.01.016","type":"journal-article","created":{"date-parts":[[2022,1,23]],"date-time":"2022-01-23T01:37:10Z","timestamp":1642901830000},"page":"184.e1-184.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["High Proliferating Regulatory T Cells Post-Transplantation Are Associated with Poor Survival in Lymphoma Patients Treated with Autologous Hematopoietic Stem Cell Transplantation"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7456-0623","authenticated-orcid":false,"given":"Nuttavut","family":"Sumransub","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rose","family":"Wangen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1997-3799","authenticated-orcid":false,"given":"Claudio","family":"Brunstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0339-4944","authenticated-orcid":false,"given":"Jeffrey S.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronika","family":"Bachanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2022.01.016_bib0001","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2022.01.016_bib0002","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","article-title":"Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma","volume":"333","author":"Philip","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2022.01.016_bib0003","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1200\/JCO.2002.09.138","article-title":"Autologous transplantation for aggressive non-Hodgkin's lymphoma: results of a randomized trial evaluating graft source and minimal residual disease","volume":"20","author":"Vose","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2022.01.016_bib0004","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1080\/10428194.2019.1581929","article-title":"Importance of early immune recovery after autologous hematopoietic cell transplantation in lymphoma patients","volume":"60","author":"Jantunen","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jtct.2022.01.016_bib0005","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/jca.21611","article-title":"Autograft immune effector cells and survival in autologous peripheral blood hematopoietic stem cell transplantation","volume":"33","author":"Porrata","year":"2018","journal-title":"J Clin Apher"},{"key":"10.1016\/j.jtct.2022.01.016_bib0006","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00412-018-0659-8","article-title":"Ki-67: more than a proliferation marker","volume":"127","author":"Sun","year":"2018","journal-title":"Chromosoma"},{"key":"10.1016\/j.jtct.2022.01.016_bib0007","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/imr.12174","article-title":"Genetic and epigenetic basis of Treg cell development and function: from a FoxP3-centered view to an epigenome-defined view of natural Treg cells","volume":"259","author":"Morikawa","year":"2014","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jtct.2022.01.016_bib0008","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.0019-2805.2003.01788.x","article-title":"CD4+ CD25+ Treg: divide and rule?","volume":"111","author":"Walker","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.jtct.2022.01.016_bib0009","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1182\/blood-2013-03-489443","article-title":"Human secondary lymphoid organs typically contain polyclonally-activated proliferating regulatory T cells","volume":"122","author":"Peters","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.01.016_bib0010","article-title":"Regulatory T cells and their prognostic relevance in hematologic malignancies","volume":"2017","author":"D'Arena","year":"2017","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jtct.2022.01.016_bib0011","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1007\/s00432-020-03398-1","article-title":"Prognostic role of regulatory T cells in lymphoma: a systematic review and meta-analysis","volume":"146","author":"Peng","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jtct.2022.01.016_bib0012","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1200\/JCO.2008.20.7209","volume":"27","author":"DiPersio","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2022.01.016_bib0013","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.bbmt.2016.06.016","article-title":"Hematopoietic progenitor cell mobilization with ifosfamide, carboplatin, and etoposide chemotherapy versus plerixafor-based strategies in patients with Hodgkin and non-Hodgkin lymphoma","volume":"22","author":"Dhakal","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.01.016_bib0014","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.jtct.2022.01.016_bib0015","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.3109\/10428194.2015.1129537","article-title":"Early immune recovery after autologous transplantation in non-Hodgkin lymphoma patients: predictive factors and clinical significance","volume":"57","author":"Valtola","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jtct.2022.01.016_bib0016","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/cei.13491","article-title":"Comprehensive flow cytometric reference intervals of leukocyte subsets from six study centers across Europe","volume":"202","author":"Oras","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jtct.2022.01.016_bib0017","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1182\/blood.V90.9.3789","article-title":"Constraints on CD4 recovery postchemotherapy in adults: thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells","volume":"90","author":"Hakim","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.01.016_bib0018","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1182\/blood.V96.2.754.014k39_754_762","article-title":"Prolonged CD4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adults","volume":"96","author":"Mackall","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.01.016_bib0019","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1074-7613(00)80664-0","article-title":"IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation","volume":"9","author":"Lodolce","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.jtct.2022.01.016_bib0020","doi-asserted-by":"crossref","first-page":"8732","DOI":"10.1073\/pnas.161126098","article-title":"IL-7 is critical for homeostatic proliferation and survival of naive T cells","volume":"98","author":"Tan","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtct.2022.01.016_bib0021","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.smim.2007.10.004","article-title":"T cell immune reconstitution following lymphodepletion","volume":"19","author":"Williams","year":"2007","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jtct.2022.01.016_bib0022","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1182\/blood-2008-08-173179","article-title":"Host CD4+CD25+ T cells can expand and comprise a major component of the Treg compartment after experimental HCT","volume":"113","author":"Bayer","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.01.016_bib0023","doi-asserted-by":"crossref","first-page":"6431","DOI":"10.4049\/jimmunol.171.12.6431","article-title":"IL-15 and cognate antigen successfully expand de novo-induced human antigen-specific regulatory CD4+ T cells that require antigen-specific activation for suppression","volume":"171","author":"Koenen","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.jtct.2022.01.016_bib0024","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1002\/eji.201141611","article-title":"Expansion of a restricted residual host T reg-cell repertoire is dependent on IL-2 following experimental autologous hematopoietic stem transplantation","volume":"41","author":"Bayer","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jtct.2022.01.016_bib0025","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1084\/jem.20051511","article-title":"CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner","volume":"202","author":"Ghiringhelli","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jtct.2022.01.016_bib0026","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nri1806","article-title":"Regulatory T cells, tumour immunity and immunotherapy","volume":"6","author":"Zou","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jtct.2022.01.016_bib0027","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/nm1312","article-title":"Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells","volume":"11","author":"Zhang","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.jtct.2022.01.016_bib0028","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.bbmt.2009.06.009","article-title":"Targeting Treg cells in situ: emerging expansion strategies for (CD4(+)CD25(+)) regulatory T cells","volume":"15","author":"Shatry","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.01.016_bib0029","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1182\/blood.V98.3.579","article-title":"Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma","volume":"98","author":"Porrata","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.01.016_bib0030","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1046\/j.1365-2141.2002.03478.x","article-title":"Early lymphocyte recovery post-autologous haematopoietic stem cell transplantation is associated with better survival in Hodgkin's disease","volume":"117","author":"Porrata","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2022.01.016_bib0031","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/sj.bmt.1704050","article-title":"Correlation of early lymphocyte recovery and progression-free survival after autologous stem-cell transplant in patients with Hodgkin's and non-Hodgkin's Lymphoma","volume":"31","author":"Gordan","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.01.016_bib0032","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/sj.bmt.1704530","article-title":"Lymphocyte recovery as a positive predictor of prolonged survival after autologous peripheral blood stem cell transplantation in T-cell non-Hodgkin's lymphoma","volume":"34","author":"Kim","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.01.016_bib0033","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1080\/10428190500126380","article-title":"The effect of absolute lymphocyte count recovery kinetics on survival after autologous stem cell transplantation for non-Hodgkin's lymphoma","volume":"46","author":"Yoong","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jtct.2022.01.016_bib0034","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.bmt.1705342","article-title":"Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma","volume":"37","author":"Joao","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.01.016_bib0035","first-page":"54","article-title":"Lymphocyte recovery and infused CD34+ cells dose: effect on the evolution after stem cell autotransplantation","volume":"2","author":"Romero Fern\u00e1ndez","year":"2013","journal-title":"Leuk Res Rep"},{"key":"10.1016\/j.jtct.2022.01.016_bib0036","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/hon.2332","article-title":"Clinical impact of early recovery of peripheral blood absolute lymphocyte count after frontline autologous stem cell transplantation for diffuse large B-cell lymphoma","volume":"35","author":"Kim","year":"2017","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.jtct.2022.01.016_bib0037","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.bbmt.2008.04.013","article-title":"Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: a prospective study","volume":"14","author":"Porrata","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.01.016_bib0038","article-title":"Interleukin-15 affects patient survival through natural killer cell recovery after autologous hematopoietic stem cell transplantation for non-Hodgkin lymphomas","volume":"2010","author":"Porrata","year":"2010","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.jtct.2022.01.016_bib0039","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/sj.bmt.1705183","article-title":"Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post transplant recovery predict survival","volume":"36","author":"Dean","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.01.016_bib0040","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2011.29.15_suppl.8018","article-title":"Day 15 peripheral blood lymphocyte\/monocyte ratio post-autologous peripheral hematopoietic stem cell transplantation and survival in diffuse large B-cell lymphoma","volume":"29","author":"Porrata","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2022.01.016_bib0041","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/658371","article-title":"Day 100 peripheral blood absolute lymphocyte\/monocyte ratio and survival in classical Hodgkin's lymphoma postautologous peripheral blood hematopoietic stem cell transplantation","volume":"2013","author":"Porrata","year":"2013","journal-title":"Bone Marrow Res"},{"key":"10.1016\/j.jtct.2022.01.016_bib0042","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13045-015-0178-5","article-title":"Infused autograft lymphocyte-to-monocyte ratio and survival in T-cell lymphoma post-autologous peripheral blood hematopoietic stem cell transplantation","volume":"8","author":"Porrata","year":"2015","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jtct.2022.01.016_bib0043","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/bjh.14433","article-title":"Increased regulatory T cell graft content is associated with improved outcome in haematopoietic stem cell transplantation: a systematic review","volume":"176","author":"Fisher","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2022.01.016_bib0044","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1182\/blood-2017-11-785865","article-title":"Immune regulatory cell infusion for graft-versus-host disease prevention and therapy","volume":"131","author":"Blazar","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.01.016_bib0045","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1182\/blood-2010-10-311894","article-title":"Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation","volume":"117","author":"Di Ianni","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.01.016_bib0046","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s12185-011-0958-9","article-title":"Reconstitution of regulatory T cells after autologous transplantation in multiple myeloma","volume":"94","author":"Ganeshan","year":"2011","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtct.2022.01.016_bib0047","doi-asserted-by":"crossref","first-page":"27305","DOI":"10.18632\/oncotarget.25553","article-title":"Increased circulating CD4+FOXP3+ T cells associate with early relapse following autologous hematopoietic stem cell transplantation in multiple myeloma patients","volume":"9","author":"Batorov","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.jtct.2022.01.016_bib0048","doi-asserted-by":"crossref","first-page":"7305","DOI":"10.4049\/jimmunol.180.11.7305","article-title":"Regulatory CD4+CD25+Foxp3+ T cells selectively inhibit the spontaneous form of lymphopenia-induced proliferation of naive T cells","volume":"180","author":"Winstead","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jtct.2022.01.016_bib0049","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1182\/blood-2007-06-096586","article-title":"Escape from suppression: tumor-specific effector cells outcompete regulatory T cells following stem cell transplantation","volume":"111","author":"Mirmonsef","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.01.016_bib0050","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/sj.bmt.1705931","article-title":"Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance","volume":"41","author":"Kline","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.01.016_bib0051","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41409-019-0591-4","article-title":"Immune profiling in diffuse large B-cell lymphoma and mantle cell lymphoma patients treated with autologous hematopoietic cell transplant","volume":"55","author":"Herr","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.01.016_bib0052","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00262-015-1729-x","article-title":"Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry","volume":"64","author":"Santegoets","year":"2015","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jtct.2022.01.016_bib0053","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.bbmt.2014.07.012","article-title":"Infused autograft lymphocyte to monocyte ratio and survival in diffuse large B cell lymphoma","volume":"20","author":"Porrata","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.01.016_bib0054","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/JBM.S75784","article-title":"Infused autograft lymphocyte to monocyte ratio predicts survival in classical Hodgkin lymphoma","volume":"6","author":"Porrata","year":"2015","journal-title":"J Blood Med"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722000379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722000379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:01:55Z","timestamp":1763002915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636722000379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S2666636722000379"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2022.01.016","relation":{},"ISSN":["2666-6367"],"issn-type":[{"type":"print","value":"2666-6367"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High Proliferating Regulatory T Cells Post-Transplantation Are Associated with Poor Survival in Lymphoma Patients Treated with Autologous Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2022.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}